2014
DOI: 10.1158/1541-7786.mcr-14-0067
|View full text |Cite
|
Sign up to set email alerts
|

Internalization by Multiple Endocytic Pathways and Lysosomal Processing Impact Maspin-Based Therapeutics

Abstract: Patients with metastatic disease face high rates of mortality with a paucity of therapeutic options. Protein-based therapeutics provides advantages over traditional chemotherapy through increased specificity, decreased immune responses and more direct means of delivery. However, development is often hindered due to insufficient knowledge regarding proteolytic processing by cells when exogenously applied. This study focuses on recombinant Maspin (rMaspin), a serine protease inhibitor (SERPINB5), which alters in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
12
0
3

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 46 publications
2
12
0
3
Order By: Relevance
“…The short time required for their influence to be seen indicates a dynamic regulation of cellular processes, similar to prior observations with full length maspin [6]. The peptides could either have been taken up into cells as recently demonstrated for full length maspin [33] or acting through cell surface receptors as discussed. Either of these mechanisms could account for the effects on downstream signalling processes demonstrated.…”
Section: Discussionsupporting
confidence: 80%
“…The short time required for their influence to be seen indicates a dynamic regulation of cellular processes, similar to prior observations with full length maspin [6]. The peptides could either have been taken up into cells as recently demonstrated for full length maspin [33] or acting through cell surface receptors as discussed. Either of these mechanisms could account for the effects on downstream signalling processes demonstrated.…”
Section: Discussionsupporting
confidence: 80%
“…Re-expression of Maspin or treatment with rMaspin decreases tumor growth and metastasis using in vivo experiments (Zou et al, 1994;Bodenstine et al, 2012;Berardi et al, 2013). Recently, a paper by Bodenstine et al, (2014) considered recombinant Maspin (rMaspin), which alters invasive properties when directly applied to cancer cells. This study indicates that cellular processing of rMaspin plays a key role by affecting its biologic activity and highlights the need for new approaches aimed at increasing the availability of rMaspin when used to treat cancer.…”
Section: Resultsmentioning
confidence: 99%
“…Low-dose maspin plus paclitaxel resulted in 41% tumor growth inhibition which was superior to maspin or paclitaxel alone (79). The r-maspin was found in cytoplasmic vesicles through multiple endocytic mechanisms of uptake (80,81). In addition to the general shortcomings of many therapeutic proteins, presently, systematic optimization of the anti-metastatic function of r-maspin is hampered by insufficient knowledge of the functional contribution of membrane-associated, cytoplasmic and nuclear maspin.…”
Section: Target Validation Experiments In Breast-and Prostate Cancerrmentioning
confidence: 99%